We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
CTKB

Price
3.99
Stock movement up
+0.07 (1.79%)
Company name
Cytek Biosciences Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Markedsværdi
513.96M
Ent værdi
457.45M
Pris/omsætning
2.55
Pris/bog
1.33
Udbytte afkast
-
Udbyttevækst
-
Vekst år
-
FCF-udbetaling
-
Efterfølgende P/E
-
Fremtidig P/E
19.00
PEG
-
EPS-vekst
-
1 års afkast
-40.45%
3 års afkast
-26.13%
5 års afkast
-
10 års afkast
-
Senest opdateret: 2025-04-02

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UDBYTTE

CTKB betaler ikke udbytte

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VÆRDIANSÆTTELSE

Værdiansættelsesforhold

Loading...
Værdiansættelsesforhold-data
Efterfølgende P/E-
Pris til OCF15.62
Pris til FCF17.91
Pris til EBITDA-
EV i forhold til EBITDA-

Værdiansættelse (salg/bogført værdi)

Loading...
Værdiansættelse (salg/bogført værdi)-data
Pris til omsætning2.55
Pris til egenkapital1.33
EV i forhold til salg2.27

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

ØKONOMI

Pr. aktie

Loading...
Data pr. aktie
Aktuelt antal aktier128.81M
EPS (TTM)-0.08
FCF pr. aktie (TTM)0.22

Resultatopgørelse

Loading...
Resultatopgørelse-data
Omsætning (TTM)201.21M
Bruttofortjeneste (TTM)110.50M
Driftsindkomst (TTM)-23.65M
Nettoindkomst (TTM)-10.16M
EPS (TTM)-0.08
EPS (1 år frem)0.21

Marginer

Loading...
Marginer-data
Bruttomargin (TTM)54.92%
Driftsmargin (TTM)-11.75%
Fortjenstmargin (TTM)-5.05%

Balance

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
Kontanter162.27M
Nettotilgodehavender52.63M
Omsætningsaktiver i alt390.19M
Goodwill16.18M
Immaterielle aktiver20.49M
Ejendomme, anlæg og udstyr0.00
Sum aktiver491.23M
Kreditor5.39M
Kortfristet/nuværende langsigtet gæld8.99M
Summen af kortfristede forpligtelser62.80M
Sum gæld105.76M
Aktionærernes egenkapital385.46M
Materielle nettoaktiver0.00

Likviditet

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
Likviditet fra driften (TTM)32.89M
Investeringsudgifter (TTM)4.19M
Fri pengestrøm (TTM)28.70M
Udbetalt udbytte (TTM)0.00

Finansiel indkomst

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
Egenkapitalafkast-2.64%
Afkast af aktiver-2.07%
Afkast af investeret kapital-2.64%
Kontant afkast af investeret kapital7.45%

iO Charts is a Seeking Alpha partner

INFORMATION OM AKTIER

Aktiediagram

Loading...
Aktiekurs-data
Åbning3.90
Daglig høj4.10
Daglig lav3.88
Daglig volumen838K
Højeste gennem alle tider27.93
1 års analytiker estimat8.40
Beta1.32
EPS (TTM)-0.08
Udbytte pr. aktie-
Ex-div dato-
Næste dato for resultatpræsentation5 Jun 2025

Nedsidepotensial

Loading...
Nedsidepotensial-data
CTKBS&P500
Nuværende prisfald fra top notering-85.71%-7.90%
Højeste prisfald-85.96%-56.47%
Højeste efterår dato1 Apr 20259 Mar 2009
Gennemsnitlig fald fra toppen-62.36%-11.07%
Gennemsnitlig tid til nyt højdepunkt116 days12 days
Maks. tid til nyt højdepunkt891 days1805 days
OPLYSNINGER OM VIRKSOMHEDEN
CTKB (Cytek Biosciences Inc) company logo
Markedsværdi
513.96M
Markedsværdi kategori
Small-cap
Beskrivelse
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Personale
645
Investor relationer
-
SEC-indsendelser
Adm. direktør
Land
USA
By
Aktietype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FORSTÅ FORRETNINGEN
Loading...